Advanced search
Publication Cover
Acta Oto-Laryngologica Volume 136, 2016 - Issue 8
Submit an article Journal homepage
119
Views
1
CrossRef citations to date
0
Altmetric
Research Article

T-status and an oral fluoropyrimidine, S-1, adjuvant chemotherapy are prognostic factors in reduced-RADPLAT for resectable hypopharyngeal cancer

Naohiro WakisakaDivision of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, JapanCorrespondence[email protected]
,
Nobuyuki HiraiDivision of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan
,
Satoru KondoDivision of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan
,
Mitsuharu AgaDivision of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan
,
Yosuke NakanishiDivision of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan
,
Akira TsujiDivision of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan
,
Kazuhira EndoDivision of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan
,
Shigeyuki MuronoDivision of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan
&
Tomokazu YoshizakiDivision of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan
 show all
Pages 834-840 | Received 16 Dec 2015, Accepted 17 Feb 2016, Published online: 23 Mar 2016

References

  • Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservation in pyriform sinus cancer: Preliminary results of a european organization for research and treatment of cancer phase III trial. Eortc head and neck cancer cooperative group. J Natl Cancer Inst 1996;88:890–99.
  • Pingree TF, Davis RK, Reichman O, Derrick L. Treatment of hypopharyngeal carcinoma: A 10-year review of 1,362 cases. Laryngoscope 1987;97:901–4.
  • Pignon JP, Bourhis J, Domenge C, Designe L Mach-NC Collaborative Group. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. Lancet 2000;355:949–55.
  • Pignon JP, le Maitre A, Maillard E, Bourhis J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009;92:4–14.
  • Robbins KT, Storniolo AM, Kerber C, Vicario D, Seagren S, Shea M, et al. Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer. J Clin Oncol 1994;12:2113–20.
  • Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091–8.
  • Wakisaka N, Kondo S, Endo K, Murono S, Yoshizaki T. Adjuvant chemotherapy with an oral fluoropyrimidine, S-1, following reduced radplat in advanced laryngeal cancer. Ann Otol Rhinol Laryngol 2012;121:555–62.
  • Yoshizaki T, Kondo S, Wakisaka N, Murono S, Kitagawa N, Tsuji A, et al. Concurrent intra-arterial chemotherapy and radiotherapy for advanced laryngeal cancer. Ann Otol Rhinol Laryngol 2009;118:172–8.
  • Nomura K, Takahara M, Katayama A, Kishibe K, Kunibe I, Katada A, et al. Intra-arterial cisplatin with concomitant radiation for advanced hypopharyngeal cancer. Laryngoscope 2013;123:916–22.
  • Samant S, Kumar P, Wan J, Hanchett C, Vieira F, Murry T, et al. Concomitant radiation therapy and targeted cisplatin chemotherapy for the treatment of advanced pyriform sinus carcinoma: Disease control and preservation of organ function. Head Neck 1999;21:595–601.
  • Sobin LH, Gospodarowicz MK, Wittekind C. 2009 TNM classification of malignant tumours, 7th ed. New York: Wiley-Blackwell.
  • Wakisaka N, Yoshida S, Kondo S, Kita M, Endo K, Tsuji A, et al. HPV status determines the efficacy of adjuvant chemotherapy with S-1, an oral fluorouracil prodrug, in oropharyngeal cancer. Ann Otol Rhinol Laryngol 2015;124:400–6.
  • Caudell JJ, Carroll WR, Spencer SA, Bonner JA. Examination of laryngoesophageal dysfunction-free survival as an endpoint in nonsurgical treatment of squamous cell carcinomas of the larynx and hypopharynx. Cancer 2011;117:4447–51.
  • Pointreau Y, Garaud P, Chapet S, Sire C, Tuchais C, Tortochaux J, et al. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst 2009;101:498–506.
  • Doweck I, Robbins KT, Samant S, Vieira F. Intra-arterial chemoradiation for t3-4 oral cavity cancer: Treatment outcomes in comparison to oropharyngeal and hypopharyngeal carcinoma. World J Surg Oncol 2008;6:2.
  • Tsukahara K, Kubota A, Hasegawa Y, Takemura H, Terada T, Taguchi T, et al. Randomized phase III trial of adjuvant chemotherapy with S-1 after curative treatment in patients with squamous-cell carcinoma of the head and neck (ACTS-HNC). PLoS One 2015;10:e0116965.
  • Tsukuda M, Ogasawara H, Kaneko S, Komiyama S, Horiuchi M, Inuyama Y, et al. [A prospective randomized trial of adjuvant chemotherapy with uft for head and neck carcinoma. Head and neck uft study group]. Gan to Kagaku Ryoho 1994;21:1169–77.
  • Doweck I, Denys D, Robbins KT. Tumor volume predicts outcome for advanced head and neck cancer treated with targeted chemoradiotherapy. Laryngoscope 2002;112:1742–9.
  • Yoshizaki T, Wakisaka N, Murono S, Kondo S, Shimizu Y, Takanaka T, et al. Intra-arterial chemotherapy less intensive than radplat with concurrent radiotherapy for resectable advanced head and neck squamous cell carcinoma: A prospective study. Ann Otol Rhinol Laryngol 2007;116:754–61.
  • Rasch CR, Hauptmann M, Schornagel J, Wijers O, Buter J, Gregor T, et al. Intra-arterial versus intravenous chemoradiation for advanced head and neck cancer: Results of a randomized phase 3 trial. Cancer 2010;116:2159–65.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.